Spaulding & Clinigene Form Partnership for Clinical Pharmacology Services

Indian Clinigene International Ltd. and U.S. Spaulding Clinical Research will cooperate to develop their clinical pharmacology services.

India's Clinigene International Ltd., a central and bioanalytical laboratory and Phase I-IV CRO, has established a partnership with Spaulding Clinical Research, LLC, a U.S.-based clinical pharmacology, cardiac core lab, and medical device manufacturer.

The partnership will give an opportunity for the two companies to engage pharmaceutical clients strategically and accelerate First-In-Human to Proof-of-Concept clinical development.

Randol Spaulding, chief executive officer of Spaulding Clinical, said, "The strengths of both companies are very complementary, with Clinigene providing the preclinical development (through sister-company Syngene), Spaulding providing FIH/SAD/MAD, and Clinigene providing DDI and efficient Proof-of-Concept, suppo